TMCnet News
Immunomodulators Market Analysis 2014 - 2025 - Research and MarketsResearch and Markets has announced the addition of the "Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025" report to their offering. The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to this new study. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases. In addition, increasing drugs resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with trgeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period. Furthermore, burgeoning presence of the key players is expected to promote the awareness levels pertaining to benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period. In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn's disease, rheumatoid arthritis, and Non-Hodgkin's Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth. For instance, in March 2015, Novartis AG entered into research collaboration with Aduro Biotech. This was carried out to enhance its next generation cancer immunotherapy product pipeline Key Topics Covered: 1 Research Methodology & Scope 2 Executive Summary 3 Immunomodulators Market Variables, Trends & Scope 4 Immunomodulators Product Estimates & Trend Analysis 5 Immunomodulators Application Estimates & Trend Analysis 6 Immunomodulators Regional Estimates & Trend Analysis, by Product and Applications 7 Competitive Landscape For more information about this report visit http://www.researchandmarkets.com/research/bhzk2c/immunomodulators View source version on businesswire.com: http://www.businesswire.com/news/home/20170113005244/en/ |
